Noho Inc (DRNK) Financial Statements (2023 and earlier)
Company Profile
Business Address |
8340 E. RAINTREE DR., UNIT D SCOTTDALE, AZ 85260 |
State of Incorp. | WY |
Fiscal Year End | December 31 |
Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | 9/30/2013 Q3 | 6/30/2013 Q2 | 1/31/2013 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 72 | 19 | 148 | (12) | 1 | ||||
Cash and cash equivalents | 72 | 19 | 148 | (12) | 1 | ||||
Receivables | 44 | 216 | 87 | 490 | 503 | ||||
Inventory, net of allowances, customer advances and progress billings | 154 | 82 | 82 | ✕ | 114 | 161 | ✕ | ||
Inventory | 154 | 82 | 82 | 114 | 161 | ||||
Prepaid expense | 50 | ✕ | |||||||
Deferred costs | (56) | (48) | (48) | ||||||
Other current assets | 13 | ✕ | |||||||
Other undisclosed current assets | 56 | 48 | 48 | (336) | (439) | ||||
Total current assets: | 270 | 298 | 170 | 32 | 465 | 213 | 1 | ||
Noncurrent Assets | |||||||||
Property, plant and equipment | 10 | 11 | 12 | 19 | 10 | 9 | |||
Intangible assets, net (including goodwill), including: | 121 | 125 | 129 | ✕ | 136 | 140 | ✕ | ||
Other undisclosed intangible assets, net (including goodwill) | 121 | 125 | 129 | ✕ | 136 | 140 | ✕ | ||
Total noncurrent assets: | 130 | 136 | 141 | 19 | 147 | 149 | |||
TOTAL ASSETS: | 400 | 434 | 310 | 51 | 612 | 362 | 1 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 755 | 767 | 75 | 943 | 946 | ||||
Interest and dividends payable | 113 | 101 | 75 | ||||||
Employee-related liabilities | 689 | 621 | |||||||
Accounts payable | 641 | 666 | 254 | 305 | |||||
Accrued liabilities | 20 | ||||||||
Debt | 561 | 723 | 508 | 125 | 31 | ||||
Deferred compensation liability | 131 | 150 | |||||||
Due to related parties | 253 | 233 | 231 | 346 | 209 | 11 | |||
Other undisclosed current liabilities | 1,989 | 1,025 | 1,325 | 305 | 468 | ||||
Total current liabilities: | 3,558 | 2,748 | 2,139 | 1,850 | 1,803 | 11 | |||
Noncurrent Liabilities | |||||||||
Other undisclosed liabilities | 22 | ||||||||
Total liabilities: | 3,558 | 2,748 | 2,139 | 1,850 | 1,803 | 32 | |||
Equity | |||||||||
Equity, attributable to parent, including: | (3,157) | (2,315) | (1,828) | (1,238) | (1,441) | (32) | |||
Common stock | 19 | 18 | 17 | 16 | 16 | 23 | |||
Common stock, share subscribed but unissued, subscriptions receivable | 1 | ||||||||
Additional paid in capital | 6,972 | 6,717 | 6,404 | 3,433 | 1,662 | (11) | |||
Accumulated deficit | (10,148) | (9,050) | (8,250) | ||||||
Other undisclosed equity, attributable to parent | (4,688) | (3,119) | (44) | ||||||
Total equity: | (3,157) | (2,315) | (1,828) | (1,238) | (1,441) | (32) | |||
TOTAL LIABILITIES AND EQUITY: | 400 | 434 | 310 | 612 | 362 | 1 |
Income Statement (P&L) ($ in thousands) Annual | Quarterly
9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | 9/30/2013 Q3 | 6/30/2013 Q2 | 1/31/2013 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 281 | 284 | 147 | (448) | 170 | 100 | ||
Cost of revenue | (14) | (152) | (79) | (91) | (56) | |||
Cost of goods and services sold | (14) | (152) | (75) | (91) | (56) | |||
Other undisclosed gross profit | 4 | |||||||
Gross profit: | 268 | 132 | 72 | 79 | 44 | |||
Operating expenses | (721) | (874) | (2,428) | 1,626 | (734) | (532) | (29) | |
Other operating income, net (Other Expenses) | 54 | 52 | ||||||
Other undisclosed operating loss | (210) | |||||||
Operating income (loss): | (453) | (742) | (2,356) | 1,416 | (601) | (435) | (29) | |
Nonoperating expense (Other Nonoperating expense) | (561) | (59) | (53) | |||||
Interest and debt expense | (18) | (23) | (33) | (54) | 52 | |||
Other undisclosed income from continuing operations before equity method investments, income taxes | 23 | |||||||
Income (loss) from continuing operations: | (1,032) | (824) | (2,442) | 1,439 | (655) | (382) | (29) | |
Income (loss) before gain (loss) on sale of properties: | (1,032) | (824) | (2,442) | 1,439 | (655) | (382) | (29) | |
Net income (loss): | (1,032) | (824) | (2,442) | 1,439 | (655) | (382) | (29) | |
Other undisclosed net income (loss) attributable to parent | 18 | 23 | 33 | (2,460) | (54) | (157) | ||
Net loss available to common stockholders, diluted: | (1,014) | (801) | (2,409) | (1,021) | (708) | (540) | (29) |
Comprehensive Income ($ in thousands)Annual | Quarterly
9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | 9/30/2013 Q3 | 6/30/2013 Q2 | 1/31/2013 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (1,032) | (824) | (2,442) | 1,439 | (655) | (382) | (29) | |
Comprehensive income (loss): | (1,032) | (824) | (2,442) | 1,439 | (655) | (382) | (29) | |
Other undisclosed comprehensive income, net of tax, attributable to parent | 10,692 | |||||||
Comprehensive income (loss), net of tax, attributable to parent: | (1,032) | (824) | 8,250 | 1,439 | (655) | (382) | (29) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.